pimagedine has been researched along with Atherogenesis in 4 studies
pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Engelen, L | 1 |
| Stehouwer, CD | 1 |
| Schalkwijk, CG | 1 |
| Machado, AP | 1 |
| Pinto, RS | 1 |
| Moysés, ZP | 1 |
| Nakandakare, ER | 1 |
| Quintão, EC | 1 |
| Passarelli, M | 1 |
| Cantero, AV | 1 |
| Portero-Otín, M | 1 |
| Ayala, V | 1 |
| Auge, N | 1 |
| Sanson, M | 1 |
| Elbaz, M | 1 |
| Thiers, JC | 1 |
| Pamplona, R | 1 |
| Salvayre, R | 1 |
| Nègre-Salvayre, A | 1 |
| Hoang, A | 1 |
| Murphy, AJ | 1 |
| Coughlan, MT | 1 |
| Thomas, MC | 1 |
| Forbes, JM | 1 |
| O'Brien, R | 1 |
| Cooper, ME | 1 |
| Chin-Dusting, JP | 1 |
| Sviridov, D | 1 |
1 review available for pimagedine and Atherogenesis
| Article | Year |
|---|---|
Current therapeutic interventions in the glycation pathway: evidence from clinical studies.
Topics: Animals; Atherosclerosis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathie | 2013 |
3 other studies available for pimagedine and Atherogenesis
| Article | Year |
|---|---|
Aminoguanidine and metformin prevent the reduced rate of HDL-mediated cell cholesterol efflux induced by formation of advanced glycation end products.
Topics: Albumins; Animals; Atherosclerosis; Cells, Cultured; Cholesterol, HDL; Diabetes Mellitus; Enzyme Inh | 2006 |
Methylglyoxal induces advanced glycation end product (AGEs) formation and dysfunction of PDGF receptor-beta: implications for diabetic atherosclerosis.
Topics: Animals; Aorta; Apolipoproteins E; Arginine; Atherosclerosis; Becaplermin; Cell Movement; Cell Proli | 2007 |
Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties.
Topics: Apolipoprotein A-I; Atherosclerosis; ATP-Binding Cassette Transporters; Biological Transport; CD11b | 2007 |